Fuchs SE (ETR:FPE)

Elevation Oncology Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	291	302	282	259	253	220
Depreciation & Amortization	102	97	93	93	86	80
Loss (Gain) From Sale of Assets	-	-	-3	-1	-	-
Asset Writedown & Restructuring Costs	-	-	5	1	-	-
Loss (Gain) on Equity Investments	-4	-3	-1	-1	-1	-10
Stock-Based Compensation	-	-	-	-	1	-
Other Operating Activities	-	-4	-10	-6	-3	2
Change in Accounts Receivable	-	-4	-6	-77	-45	4
Change in Inventory	-15	-22	89	-131	-132	12
Change in Accounts Payable	29	13	34	2	25	18
Change in Other Net Operating Assets	3	11	60	-11	-15	34
Operating Cash Flow	406	390	543	128	169	360
Operating Cash Flow Growth	-8.14%	-28.18%	324.22%	-24.26%	-53.06%	9.42%
Capital Expenditures	-87	-83	-83	-69	-80	-122
Sale of Property, Plant & Equipment	1	1	5	2	1	-
Cash Acquisitions	-123	-101	-4	-2	-29	-114
Investment in Securities	-2	-2	-	-	-	-
Investing Cash Flow	-211	-185	-82	-69	-108	-236
Long-Term Debt Issued	-	5	-	119	5	1
Long-Term Debt Repaid	-	-	-133	-	-	-
Net Debt Issued (Repaid)	-14	5	-133	119	5	1
Repurchase of Common Stock	-12	-79	-122	-62	-	-
Common Dividends Paid	-153	-146	-144	-142	-137	-134
Other Financing Activities	-7	-8	-1	-1	-	-1
Financing Cash Flow	-186	-228	-400	-86	-132	-134
Foreign Exchange Rate Adjustments	-7	1	-5	-	8	-
Net Cash Flow	2	-22	56	-27	-63	-10
Free Cash Flow	319	307	460	59	89	238
Free Cash Flow Growth	-13.55%	-33.26%	679.66%	-33.71%	-62.60%	36.00%
Free Cash Flow Margin	8.95%	8.71%	12.99%	1.73%	3.10%	10.01%
Free Cash Flow Per Share	2.44	2.33	3.41	0.43	0.64	1.71
Cash Interest Paid	9	9	12	9	5	5
Cash Income Tax Paid	119	119	107	111	121	70
Levered Free Cash Flow	293.77	248.65	450.66	37.99	38.95	219.8
Unlevered Free Cash Flow	300.02	254.27	458.16	43.61	42.07	223.55
Change in Net Working Capital	-17	34	-188	209	187	-72

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.